NCT02777463 The Prediction Using Diffusion MRI of the Response Evaluation in BRPC in NAT. Status COMPLETED Phase N/A
NCT02767752 Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT02756468 Procalcitonin Reveals Early Dehiscence in Pancreatic Surgery: the PREDIPS Study Status UNKNOWN Phase N/A
NCT02745847 Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer Status UNKNOWN Phase NA
NCT02745197 A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer Status WITHDRAWN Phase PHASE2
NCT02743975 Near-infrared Image Guided Surgery in Pancreatic Adenocarcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT02734680 IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer Status UNKNOWN Phase NA
NCT02723331 Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates Status COMPLETED Phase PHASE2
NCT02720666 K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability Status COMPLETED Phase PHASE1
NCT02718859 Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02713984 A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT02713529 Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02707328 Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) Status TERMINATED Phase PHASE1
NCT02707315 A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer Status UNKNOWN Phase EARLY_PHASE1
NCT02706782 A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma Status UNKNOWN Phase PHASE1
NCT02705196 LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02704156 SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT02704143 Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer Status COMPLETED Phase NA
NCT02702986 Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC) Status COMPLETED Phase PHASE1